ConcertAI’s TeraRecon Offers New Suite to Eureka Clinical AI Platform

Image Credit: Adobe Stock Images/jahidsuniverse

ConcertAI’s TeraRecon, a clinical AI SaaS company, broke the news that its Eureka Clinical AI platform's Cardio Suite now provides clinicians with the artificial intelligence and deep learning technology necessary to help identify, treat, and manage cardiovascular disease.

"The Cardio Suite represents our second installment of dedicated care area suites following the launch of the Neuro Suite earlier this year," said Dan McSweeney, President, TeraRecon. "We are committed to supporting cardiologists and clinicians by bringing novel AI powered solutions, such as our Cardio Suite, forward to more efficiently help physicians screen and diagnose cardiac disease patients so that appropriate treatments can be delivered."

Reference: ConcertAI's TeraRecon Adds Cardio Suite to its Eureka Clinical AI Platform. PR Newswire. August 30, 2023. Accessed September 5, 2023. https://www.prnewswire.com/news-releases/concertais-terarecon-adds-cardio-suite-to-its-eureka-clinical-ai-platform-301912876.html